Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Irinotecan in Treating Patients With Advanced Cancer of the Stomach
A Phase II Trial of CPT-11 in Patients With Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Incorporating Pretreatment and Posttreatment Biopsies for Evaluation of Tumor Thymidylate Synthase, MIB-1, Topoisomerase I, and p53
Status: Enrolling
Updated:  7/7/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Irinotecan in Treating Patients With Advanced Cancer of the Stomach
A Phase II Trial of CPT-11 in Patients With Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Incorporating Pretreatment and Posttreatment Biopsies for Evaluation of Tumor Thymidylate Synthase, MIB-1, Topoisomerase I, and p53
Status: Enrolling
Updated: 7/7/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Cancer of the Stomach
A Phase II Trial of CPT-11 in Patients With Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Incorporating Pretreatment and Posttreatment Biopsies for Evaluation of Tumor Thymidylate Synthase, MIB-1, Topoisomerase I, and p53
Status: Enrolling
Updated:  7/7/2015
CentraCare Clinic
mi
from
Saint Cloud, MN
Irinotecan in Treating Patients With Advanced Cancer of the Stomach
A Phase II Trial of CPT-11 in Patients With Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Incorporating Pretreatment and Posttreatment Biopsies for Evaluation of Tumor Thymidylate Synthase, MIB-1, Topoisomerase I, and p53
Status: Enrolling
Updated: 7/7/2015
CentraCare Clinic
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Cancer of the Stomach
A Phase II Trial of CPT-11 in Patients With Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Incorporating Pretreatment and Posttreatment Biopsies for Evaluation of Tumor Thymidylate Synthase, MIB-1, Topoisomerase I, and p53
Status: Enrolling
Updated:  7/7/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Irinotecan in Treating Patients With Advanced Cancer of the Stomach
A Phase II Trial of CPT-11 in Patients With Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Incorporating Pretreatment and Posttreatment Biopsies for Evaluation of Tumor Thymidylate Synthase, MIB-1, Topoisomerase I, and p53
Status: Enrolling
Updated: 7/7/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Cancer of the Stomach
A Phase II Trial of CPT-11 in Patients With Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Incorporating Pretreatment and Posttreatment Biopsies for Evaluation of Tumor Thymidylate Synthase, MIB-1, Topoisomerase I, and p53
Status: Enrolling
Updated:  7/7/2015
Medcenter One Health System
mi
from
Bismarck, ND
Irinotecan in Treating Patients With Advanced Cancer of the Stomach
A Phase II Trial of CPT-11 in Patients With Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Incorporating Pretreatment and Posttreatment Biopsies for Evaluation of Tumor Thymidylate Synthase, MIB-1, Topoisomerase I, and p53
Status: Enrolling
Updated: 7/7/2015
Medcenter One Health System
mi
from
Bismarck, ND
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Cancer of the Stomach
A Phase II Trial of CPT-11 in Patients With Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Incorporating Pretreatment and Posttreatment Biopsies for Evaluation of Tumor Thymidylate Synthase, MIB-1, Topoisomerase I, and p53
Status: Enrolling
Updated:  7/7/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Irinotecan in Treating Patients With Advanced Cancer of the Stomach
A Phase II Trial of CPT-11 in Patients With Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Incorporating Pretreatment and Posttreatment Biopsies for Evaluation of Tumor Thymidylate Synthase, MIB-1, Topoisomerase I, and p53
Status: Enrolling
Updated: 7/7/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Cancer of the Stomach
A Phase II Trial of CPT-11 in Patients With Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Incorporating Pretreatment and Posttreatment Biopsies for Evaluation of Tumor Thymidylate Synthase, MIB-1, Topoisomerase I, and p53
Status: Enrolling
Updated:  7/7/2015
Altru Health Systems
mi
from
Grand Forks, ND
Irinotecan in Treating Patients With Advanced Cancer of the Stomach
A Phase II Trial of CPT-11 in Patients With Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Incorporating Pretreatment and Posttreatment Biopsies for Evaluation of Tumor Thymidylate Synthase, MIB-1, Topoisomerase I, and p53
Status: Enrolling
Updated: 7/7/2015
Altru Health Systems
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Cancer of the Stomach
A Phase II Trial of CPT-11 in Patients With Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Incorporating Pretreatment and Posttreatment Biopsies for Evaluation of Tumor Thymidylate Synthase, MIB-1, Topoisomerase I, and p53
Status: Enrolling
Updated:  7/7/2015
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Irinotecan in Treating Patients With Advanced Cancer of the Stomach
A Phase II Trial of CPT-11 in Patients With Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Incorporating Pretreatment and Posttreatment Biopsies for Evaluation of Tumor Thymidylate Synthase, MIB-1, Topoisomerase I, and p53
Status: Enrolling
Updated: 7/7/2015
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Cancer of the Stomach
A Phase II Trial of CPT-11 in Patients With Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Incorporating Pretreatment and Posttreatment Biopsies for Evaluation of Tumor Thymidylate Synthase, MIB-1, Topoisomerase I, and p53
Status: Enrolling
Updated:  7/7/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Irinotecan in Treating Patients With Advanced Cancer of the Stomach
A Phase II Trial of CPT-11 in Patients With Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Incorporating Pretreatment and Posttreatment Biopsies for Evaluation of Tumor Thymidylate Synthase, MIB-1, Topoisomerase I, and p53
Status: Enrolling
Updated: 7/7/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Cancer of the Stomach
A Phase II Trial of CPT-11 in Patients With Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Incorporating Pretreatment and Posttreatment Biopsies for Evaluation of Tumor Thymidylate Synthase, MIB-1, Topoisomerase I, and p53
Status: Enrolling
Updated:  7/7/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Irinotecan in Treating Patients With Advanced Cancer of the Stomach
A Phase II Trial of CPT-11 in Patients With Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Incorporating Pretreatment and Posttreatment Biopsies for Evaluation of Tumor Thymidylate Synthase, MIB-1, Topoisomerase I, and p53
Status: Enrolling
Updated: 7/7/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Irinotecan in Treating Patients With Advanced Cancer of the Stomach
A Phase II Trial of CPT-11 in Patients With Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Incorporating Pretreatment and Posttreatment Biopsies for Evaluation of Tumor Thymidylate Synthase, MIB-1, Topoisomerase I, and p53
Status: Enrolling
Updated:  7/7/2015
Allan Blair Cancer Centre
mi
from
Regina,
Irinotecan in Treating Patients With Advanced Cancer of the Stomach
A Phase II Trial of CPT-11 in Patients With Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Incorporating Pretreatment and Posttreatment Biopsies for Evaluation of Tumor Thymidylate Synthase, MIB-1, Topoisomerase I, and p53
Status: Enrolling
Updated: 7/7/2015
Allan Blair Cancer Centre
mi
from
Regina,
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated:  7/7/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated: 7/7/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Wichita
mi
from
Wichita, KA
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Duluth
mi
from
Duluth, MN
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated:  7/7/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated: 7/7/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated:  7/7/2015
CentraCare Clinic
mi
from
Saint Cloud, MN
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated: 7/7/2015
CentraCare Clinic
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated:  7/7/2015
Medcenter One Health System
mi
from
Bismarck, ND
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated: 7/7/2015
Medcenter One Health System
mi
from
Bismarck, ND
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated:  7/7/2015
Altru Health Systems
mi
from
Grand Forks, ND
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated: 7/7/2015
Altru Health Systems
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated:  7/7/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated: 7/7/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach
A Phase I Study of Gemcitabine, Cisplatin, and Radiation Therapy in Patients With Locally Advanced Pancreatic and Gastric Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Wichita
mi
from
Wichita, KA
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Ochsner
mi
from
New Orleans, LA
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Ochsner
mi
from
New Orleans, LA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Ann Arbor Regional
mi
from
Ann Arbor, MI
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Ann Arbor Regional
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Duluth
mi
from
Duluth, MN
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CentraCare Clinic
mi
from
Saint Cloud, MN
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CentraCare Clinic
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
Medcenter One Health System
mi
from
Bismarck, ND
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
Medcenter One Health System
mi
from
Bismarck, ND
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
Altru Health Systems
mi
from
Grand Forks, ND
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
Altru Health Systems
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated:  7/7/2015
Allan Blair Cancer Centre
mi
from
Regina,
Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Randomized Phase II Trial of Irinotecan (CPT-11) In Patients With Refractory Metastatic Breast Cancer
Status: Enrolling
Updated: 7/7/2015
Allan Blair Cancer Centre
mi
from
Regina,
Click here to add this to my saved trials